Mankind Pharma Limited has informed the Exchange about Schedule of meet
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma Limited has submitted a Schedule of Meeting to the National Stock Exchange (NSE), as required under listing regulations. The filing notifies the exchange of an upcoming scheduled meeting, though the specific type of meeting (board meeting, general meeting, or analyst/investor meet), agenda, and date have not been provided in the headline excerpt. Such filings are routine compliance disclosures made before key corporate meetings. Further details on the meeting's purpose and outcomes would typically follow in a separate announcement.
Schedule of meeting filings are standard compliance disclosures and usually do not have a direct material impact on the stock price. Shareholders should watch for the subsequent detailed announcement to learn about any key decisions, results, or strategic actions from the meeting.